Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hikma Pharmaceuticals Plc (OP: HKMPF ) 25.16 UNCHANGED Last Price Updated: 2:53 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Hikma Pharmaceuticals Plc Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production September 06, 2024 Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and globally. Via Benzinga Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices August 28, 2024 Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing higher drug prices. Plaintiffs accuse Jazz of antitrust violations and... Via Benzinga Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape June 12, 2023 The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March. Methotrexate is an injected medication utilized to treat... Via Benzinga Week In Review: Ten Biggest 2022 China Biopharma Deals Worth $21.5 Billion December 31, 2022 China Biopharma deal activity in 2022 was certainly slower than the previous year, but the ten largest deals, many of them booked in the second half of the year, totaled a decent $21.5 billion by... Via Talk Markets Up On Bad News March 22, 2022 Despite the plane crash in China, Boeing's stock is up today. Via Talk Markets A Peek Into The Markets: US Stock Futures Mostly Higher; Crude Oil Rises Over 1% September 27, 2021 Pre-open movers U.S. stock futures traded mostly higher in early pre-market trade after recording a slight gain in the previous session. Investors are awaiting earnings results... Via Benzinga Exposures Fossil Fuels Hikma Bolsters Injectable Portfolio With $375M Custopharm Acquisition September 27, 2021 Hikma Pharmaceuticals Plc (OTC: HKMPF) has agreed to acquire US-based generic sterile injectables producer Custopharm Inc from Water Street... Via Benzinga Wonder Products June 02, 2021 Meme is alive and well. Via Talk Markets Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.